市场调查报告书
商品编码
1298809
2023-2028年按类型(复合药片、黄体酮药片和其他)、分销渠道(零售店、网店和其他)和地区分類的紧急避孕药市场Emergency Contraceptive Pills Market by Type (Combination Pills, Progesterone Pills, and Others), Distribution Channel (Retail Stores, Online Stores, and Others), and Region 2023-2028 |
全球紧急避孕药市场规模在2022年达到5.612亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到7.367亿美元,在2023-2028年期间呈现4.74%的增长率(CAGR)。大众对避孕和计划生育的认识不断提高,政府和非政府组织(NGO)实施支持性政策,以及最近非荷尔蒙类紧急避孕药的发展,是推动市场发展的一些关键因素。
紧急避孕药(ECPs)是指用于防止意外怀孕的节育药物。它们使用合成激素制造,如左炔诺孕酮,延迟排卵,改变子宫内膜,并防止卵子受精。ECPs被广泛用于传统避孕方法失败时、无保护的性交后、作为缺少常规避孕药的备份,以及性侵犯犯罪的受害者。它们是安全的、具有成本效益的、可获得的和高度便利的药物,不会造成长期的生育问题,成功地防止意外怀孕,并消除了堕胎的需要。ECPs还能更好地控制生殖健康,赋予妇女权力,减少焦虑和压力,并将副作用降到最低。
群众对避孕和计划生育的认识不断提高是推动市场增长的关键因素之一。紧急避孕药作为一种安全、方便、高度舒适的紧急避孕方式被妇女广泛使用,它可以防止意外怀孕,维护隐私,并将副作用和未来并发症的风险降到最低。此外,由于无保护的性交和性侵犯导致的意外怀孕的发生率上升,产品的广泛使用也是另一个增长的诱导因素。此外,政府和非政府组织(NGO)实施支持性政策,传播意识,教育群众,并提供方便的紧急避孕措施,对市场增长产生了积极的影响。此外,最近开发的非激素类ECPs,含有醋酸乌利司他,与传统的左炔诺孕酮药丸相比,能阻断体内的孕激素受体,产生的副作用更少,这也为市场增长提供了动力。除此之外,由于全球范围内对女性健康和福祉的日益关注,产品的采用率不断上升,有利于市场的增长。除此之外,对不需要处方的非处方药(OTC)产品的需求增长,以及妇女在紧急情况下可以方便地获得这些产品,也支持了市场的增长。此外,制造商通过社交媒体、影响者营销、电视(TV)广告和名人代言开展的积极宣传和品牌推广活动,也促进了市场增长。其他因素,包括消费者支出能力的提高,广泛的研究和开发(R&D)活动,以及在电子商务平台上容易获得产品,预计将推动市场增长。
请注意,这只代表部分公司的名单,完整的名单已在报告中提供。
The global emergency contraceptive pills market size reached US$ 561.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 736.7 Million by 2028, exhibiting a growth rate (CAGR) of 4.74% during 2023-2028. The increasing awareness among the masses regarding contraception and family planning, the implementation of supportive policies by governments and non-governmental organizations (NGOs), and the recent development of non-hormonal ECPs represent some of the key factors driving the market.
Emergency contraceptive pills (ECPs) refer to birth control medications used for preventing unwanted pregnancies. They are manufactured using synthetic hormones, such as levonorgestrel, which delays ovulation, changes the linings of the uterus, and prevents egg fertilization. ECPs are widely used during the failure of traditional methods of contraception, after unprotected sexual intercourse, as a backup for missing routine birth control pills, and by the victims of sexual assault crimes. They are safe, cost-effective, accessible, and highly convenient medications that do not cause long-term fertility issues, successfully prevent unintended pregnancies, and eliminate the need for abortions. ECPs also provide better control over reproductive health, empower women, reduce anxiety and stress, and minimize side effects.
The increasing awareness among the masses regarding contraception and family planning is one of the key factors propelling the market growth. ECPs are widely used by women as a safe, convenient, and highly comfortable form of emergency contraception, which prevents unwanted pregnancies, maintains privacy, and minimizes the risks of side effects and future complications. Along with this, the widespread product utilization due to rising incidences of unintended pregnancies owing to unprotected intercourse and sexual assault is acting as another growth-inducing factor. Furthermore, the implementation of supportive policies by governments and non-governmental organizations (NGOs) to spread awareness, educate the masses, and provide easy access to emergency contraception is positively influencing the market growth. Additionally, the recent development of non-hormonal ECPs, which contains ulipristal acetate that blocks progesterone receptors in the body and produces fewer side effects compared to traditional levonorgestrel-based pills, is providing an impetus to the market growth. Apart from this, the rising product adoption owing to the increasing focus on women's health and well-being across the globe is favoring the market growth. Besides this, the growing demand for over-the-counter (OTC) products that don't require prescriptions and can be easily accessed by women in case of emergency is supporting the market growth. Moreover, aggressive promotional and branding campaigns by manufacturers through social media, influencer marketing, television (TV) commercials, and celebrity endorsement are contributing to the market growth. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, and easy product availability across e-commerce platforms, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global emergency contraceptive pills market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type and distribution channel.
Combination Pills
Progesterone Pills
Others
The report has provided a detailed breakup and analysis of the emergency contraceptive pills market based on the type. This includes combination pills, progesterone pills, and others. According to the report, combination pills represented the largest segment.
Retail Stores
Online Stores
Others
A detailed breakup and analysis of the emergency contraceptive pills market based on the distribution channel has also been provided in the report. This includes retail stores, online stores, and others. According to the report, retail stores accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for emergency contraceptive pills. Some of the factors driving the North America emergency contraceptive pills market included the increasing awareness regarding women's health, supportive government policies, and significant technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global emergency contraceptive pills market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Afaxys Pharma LLC, Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Limited, Perrigo Company plc, Piramal Enterprises Ltd., Syzygy Healthcare Solutions LLC, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.